Skip to main content

Chronic Liver Disease

  • Living reference work entry
  • First Online:
Geriatric Diseases

Abstract

The prevalence of chronic liver disease is increasing in the elderly. More than two-thirds of all patients with liver disease in the Western world are due to alcohol liver disease (ALD) and hepatitis C virus occurring alone or in combination. Viral infections are the commonest cause of chronic liver disease which includes alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), autoimmune hepatitis, drug-induced hepatitis and metabolic diseases such as alpha-antitrypsin deficiency. There is no age-related liver diseases, but the clinical course in the elderly differs in several aspects from those of younger adults. NAFLD is one of the most common liver disorders seen by the primary care physician. Autoimmune hepatitis occurs uncommonly in the elderly; nevertheless there have been several studies in the elderly. Drug-induced liver injury embraces a spectrum of clinical disease ranging from asymptomatic, liver test abnormalities to acute liver failure and to a lesser extent chronicity. Primary biliary cirrhosis is now recognised more frequently than previously because of the increased awareness of the condition and the availability of diagnostic tools leading to earlier diagnosis. Provided hereditary haemochromatosis is detected early and treated, the life expectancy can be normal before cirrhosis occurs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Frith J, Jones D, Newton Jl. The prevalence of chronic liver disease is increasing in the elderly. Age Aging. 2009; 38(1):11–18.

    Article  Google Scholar 

  2. British Society of Gastroenterology. Care of patients with gastrointestinal disorders in the United Kingdom. An evidenced based strategy for the future. London. British Society of Gastroenterology. March 2005.

    Google Scholar 

  3. Walsh K, Alexander G. Alcoholic liver disease. Postgrad Med J. 2000;76: 280–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Office for National Statistics: Health Service Quarterly, Winter. 2008;No:40 p 59–60.

    Google Scholar 

  5. Brave A, Khan R, Marsano L, Ravindra KV, McClaine C. Treatment of alcoholic liver disease Ann Hepatol. 2008;7(1):5–15 .

    Google Scholar 

  6. Mueller S, Millonig G, Seitz HK, Alcoholic liver disease and hepatitis C: a frequently understood combination. World Gastrenterol. 2009;15(28):3462–71.

    Article  CAS  Google Scholar 

  7. The Hepatitis C Trust and the University of Southampton, Losing the fight against hepatitis C, London 2005.

    Google Scholar 

  8. Floreani A. Liver damage in the elderly with an update. Dig Dis. 2007;25(2):138–43.

    Article  PubMed  Google Scholar 

  9. British Liver Trust, 2014. http://www.britishlivertrust.org.uk/about-us/media-centre/facts-about-liver-disease/retreived 23 September 2014.

  10. Teli MR, Day CP, Burt AD. Determinants of progression to cirrhosis or fibrosis in pure alcohol fatty liver. Lancet. 1995; 346:1562–3.

    Article  Google Scholar 

  11. Corrao G, Arico S, Zambon A, Torchio P, Aricos S, Lavecchia C, et al. Is alcohol a risk factor for liver cirrhosis in HBsAg and antiHCV negative subjects. Collective group for the study of liver disease in Italy. J Hepatol. 1997; 27:470–6.

    Article  CAS  PubMed  Google Scholar 

  12. Bellantai S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, et al, Drinking habits as cofactors of risk for induced liver damage. The Dionysos Study Group. Gut. 1997;41:845–50.

    Article  Google Scholar 

  13. Mihas AA, Hung PD, Hueman DM. Alcoholic hepatitis. e-medicine. updated June 30,2008.

    Google Scholar 

  14. Nagaratnam N, Peiris DC. Acute alcoholic hepatitis in Ceylon. Cey Med J 1971; 21: 28–38.

    Google Scholar 

  15. Altamirano J, Bataller R. Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol. 2011;8(9): 491–501.

    Article  CAS  PubMed  Google Scholar 

  16. James OTW. Parenchymal liver disease in the elderly. Gut. 1997;41:430–432.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Pinzani M, Roselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol 2011; 25(2):281–90 .

    Article  CAS  PubMed  Google Scholar 

  18. Scholmerich J, Holstege A. Aetiology and pathophysiology of chronic liver disorders. Drugs. 1990;40 suppl 3: 3–22 .

    Article  PubMed  Google Scholar 

  19. Gramenzi A, Caputo F, Baselli M, Kuria F, Loggi E, Andreone P, et al. review article: Alcoholic liver disease: pathophysiological aspects and risk factors. Aliment Pharmocol Ther. 2006; 24:1151–1161.

    Article  CAS  Google Scholar 

  20. Galambos JT. Natural history of alcoholic hepatitis 3. Histological changes. Gastroenterol. 1972; 63:1026–35.

    CAS  Google Scholar 

  21. Zhang FK, Zhang JV, Jia JD. Treatment of patients with alcoholic liver disease. Hepatbiliary Pancreat Dis Int. 2005;4(1):72–7.

    Google Scholar 

  22. Frazier TH, Stocker AM, Kershner NK, Marsno LS, McClain CJ. Treatment of alcoholic liver disease. Ther Adv Gastroenterol. 2011;4(1):63–81.

    Article  Google Scholar 

  23. Frezza M, di Padova C, Pozzato G, Terpin M, Barona E, Lieb WCS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. NEJM. 1990; 322:95–99.

    Article  CAS  PubMed  Google Scholar 

  24. Day CP. Treatment of alcoholic liver disease. Liver Transpl. 2007; 13(11 Suppl 2):S69–75.

    Article  PubMed  Google Scholar 

  25. Hoofnagle JH, Kresina T, Fuller RK, Lake JR, Lucey MD, Sorrel MF, et al. Liver transplantation for a LD: executive statement and summary of recommendations-summary of a National Institutes of Health workshop held December 6–7, 1966, Bethesda, Maryland. Liver Transpl Surg. 1997; 3:347–50.

    Article  CAS  PubMed  Google Scholar 

  26. Bergquest CJ, Skoien R, Horsfall, Clouston AD, Jonsson JR, Powell EE. Awareness and experiences of non-alcoholic fatty liver disease by hospital patients in France. J Hepatol. 2012; 57:376–383.

    Article  Google Scholar 

  27. Clark JM. The epidemiology of non-alcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006; 40, (suppl-1:S5–10

    PubMed  Google Scholar 

  28. Raszeja-Wyszomirska J, Lawniczal M, Marlisz W, Miczynska-Kurtez J, Milkiewicz P. Non-alcoholic fatty liver disease –new review. Pol Merkur Lekarski. 2008;24(144):568–71 .

    CAS  PubMed  Google Scholar 

  29. Farrell GC, Larker CZ. Non-alcoholic fatty liver disease from steatosis to cirrhosis. Hepatology. 2006;43(2supp 11):S99–S112.

    Article  CAS  PubMed  Google Scholar 

  30. Yu AS, Keeffe ED. Non-alcoholic fatty liver disease. Rev Gastroenterol Disord. 2002;2(1):11–9.

    PubMed  Google Scholar 

  31. Koehler EM, Schonten JN, Hansen BE, van Roolj FJ, Hofman A, Strickler BH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam Study. H Hepatol. 2012;15(6):1305–11.

    Article  Google Scholar 

  32. Frith J, Day CO, Alstair AD, Newton JL. Non-alcoholic fatty liver disease in older people. Gerontology. 2009;55:6–7–615.

    Article  Google Scholar 

  33. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW, et al. The natural history of non-alcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11:74–80.

    Article  PubMed  Google Scholar 

  34. Adams LA, Talwahar JA. Diagnostic evaluation of non-alcoholic fatty liver disease. J Clin Gastroenterol. 2006;40 sup 1: S34–6.

    CAS  PubMed  Google Scholar 

  35. Clouston AD, Powell EE. Nonalcoholic fatty liver disease: is all the fat bad?. Int Med J. 2004;34:187–191.

    Article  CAS  Google Scholar 

  36. Kichian K, McLean R, Gramlich LM, Bailey RJ, Bain VG. Can J Gastroenterol. 2002;17(1):38–42.

    Article  Google Scholar 

  37. Arrospide MT. Non-alcoholic fatty liver disease. Rev Gastroenterol Peru. 2013;23(1):49–57 .

    Google Scholar 

  38. Newton JL, Burt AD, Park JB, Mathew J, Bassendine MF, James OFW. Autoimmune hepatitis in older patients. Age Ageing. 1997; 21:441–444.

    Article  Google Scholar 

  39. Selby CD, Toghill PJ. Chronic active hepatitis in the elderly. Age Ageing. 1986; 15:350–56.

    Article  CAS  PubMed  Google Scholar 

  40. Schramm C, Kanzler S, zum Buschenfelde KH, Galle PR, Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol 2001; 96(5):1587–91.

    Article  CAS  PubMed  Google Scholar 

  41. Parker DR, Kingham JGC. Type1 auto-immune hepatitis in patients in later life. Q J Med 1997; 90:289–296.

    Article  CAS  Google Scholar 

  42. Al-Chalabi T, Boccato S, Portmann DC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: A systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol. 2006;45(4):575–583.

    Article  PubMed  Google Scholar 

  43. Zeniya M, Takahashi H. Characteristics of autoimmune hepatitis in the Asia-pacific region, historical review. Hepatol Internat. 2012; 6(1):342–349.

    Article  Google Scholar 

  44. Berg PA, Klein R. Autoimmune hepatitis and overlap syndromes: diagnosis. Praxis (Bern 199). 2002;91(34):1339–46.

    Article  CAS  Google Scholar 

  45. Final Diagnosis-Autoimmune hepatitis, Type 1. http://path.upmc.edu/cases/cause 554/dx.html

  46. Wolf DC, Raghuraman UV. Autoimmune hepatitis. e-medicine update July 24, 2007.

    Google Scholar 

  47. Nagaratnam N, Ambepitiya G, Rajaratnam RG. Lupoid hepatitis, Rendu-Osler-Weber syndrome, clubbing, cyanosis and hypertrophic osteoarthropathy. J Med. 1975; 3&4:291–301.

    Google Scholar 

  48. Fallatah HI, Akbar HO. Autoimmune hepatitis as a unique form of an autoimmune liver disease: Immunological aspects and clinical overview. Autoimmune diseases. vol 2012(2012) Article ID 312517,17pr doi. 10.1155/2012/312817.

  49. Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol. 2000;32(1):181–97 .

    Article  CAS  PubMed  Google Scholar 

  50. Johnson PJ, Mcfarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998–1005.

    Article  CAS  PubMed  Google Scholar 

  51. Rangnekar AS, Fontana RJ. An update on drug induced liver injury. Minerva Gastroenterol Dietol. 2011;57(2):213–29.

    CAS  PubMed  Google Scholar 

  52. Bell LN, Chalasani N. Epidemiology of idiosyncratic drug induced liver injury. Semin Liver Dis. 2009;29(4):337–347.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Nourjah P, Ahmad SR, Karwoski C, Willy T. Estimation of acetaminophen (paracetamol) associated overdoses in the United States. Pharmacoepdemiol Dry Sap. 2006; 15 (6):398–405.

    Article  Google Scholar 

  54. Rowden AK, Norvall J, Eldridge Dl, Kirk MA. Updates on acetaminophen toxicity. Med Clin Nth Am 2005;89(6):1145–1159.

    Article  CAS  Google Scholar 

  55. Idilman R, Bektas M, Cinar K. The characteristics and clinical outcome of drug induced liver injury: a single center experience. J Clin Gastroenterol. 2010; 44 (6):128–32.

    Article  Google Scholar 

  56. Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf. 2007; 6 (6): 673–84 .

    Article  CAS  PubMed  Google Scholar 

  57. Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf. 2007; 30(4):277–94.

    Article  CAS  PubMed  Google Scholar 

  58. Ghabril M, Chalasani N, Bjornsson E. Drug-induced liver injury: a clinical update. Curr Opin Gastroenterol. 2010; 26 (3):222–226.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Kaplowitz N. Drug-induced liver injury. Clin Infect Dis. 2004;38 Suppl 2:S44–8.

    Article  PubMed  Google Scholar 

  60. Andrade RJ, Lucena MI, Kaplowitz N, Garcia-Munoz B, Borraz Y, Paclkoria K, et al. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology. 2006; 44 (6):1581–8 .

    Article  CAS  PubMed  Google Scholar 

  61. Russo MW, Scobey M, Bonkovsky HL. Drug-induced liver injury associated with statins. Semin Liver Dis. 2009;29(4):412–22.

    Article  CAS  PubMed  Google Scholar 

  62. Verma S, Kaplowitz N. Diagnosis, management and prevention of drug- induced liver injury. Gut 2009; 58 (11):1555–64.

    Article  CAS  PubMed  Google Scholar 

  63. Mehta N, Ozick L, Gbadehan E. Drug induced hepatitis. e-medicine. updated 28, 2008.

    Google Scholar 

  64. Kumagi T, Heathcote EJ. Primary biliary cirrhosis. Orphanet J Rare Dis. 2008.;23:3:1 doi 10.1186/1756-1179-3-1.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Talwalkar JA, Lindor K. Primary biliary cirrhosis. Lancet. 2003;362:53–61.

    Article  CAS  PubMed  Google Scholar 

  66. Hohenester S, Oude-Elferink RP, Beuer S. Primary biliary cirrhosis. Semin immunopathol. 2009;31(3):283–307.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Kulper EM, den Ouden-Muller JW, van Buurin HK. Primary biliary cirrhosis Ned Tijdschr Geneeski. 2009;153:A483 .

    Google Scholar 

  68. Chon CY, Park JY. Primary biliary cirrhosis. Korean J Hepatol. 2006; 12(3):364–72.

    PubMed  Google Scholar 

  69. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. NEJM. 2005;353:1261–1273.

    Article  CAS  PubMed  Google Scholar 

  70. Nishio A, Keeffe EB, Ishibashi H, Gershwin ER. Diagnosis and treatment of primary biliary cirrhosis. Med Sci Monit. 2000; 6(1): 181–93.

    CAS  PubMed  Google Scholar 

  71. McClune CA, Al-Jader LN, May A, Hayes SL, Jackson HA, Worwood M. Hereditary haemochromatosis: only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload. Hum Genet. 2002;111:538–543.

    Article  Google Scholar 

  72. Hanson EH, Imperatore G, Burke W. HFE Gene and hereditary hemochromatosis: A HuGE review’. Am J Epidemol 2001;154(3):193–206.

    Article  CAS  Google Scholar 

  73. Bacon BR, Powell LW, Adams PC, Kersina TT, Hofnagle JK. Molecular medicine and haemochromatosis: at the cross roads. Gastroenterology. 1999;116:193–207.

    Article  CAS  PubMed  Google Scholar 

  74. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test. 2000;4:183–98.

    Article  CAS  PubMed  Google Scholar 

  75. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Ann Rev Nutr. 2006;26:323–42.

    Article  CAS  Google Scholar 

  76. Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anaemia in the 21st century. Therap Adv Gastroenterol. 2011;4(3):177–184.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Burke WD, Thomson E, Khoury MJ, McDonell SM, Press N, Adams PC, et al Hereditary haemochromatosis: gene discovery and its implications for population-based screening. J Am Med Assoc.1998;280:172–78.

    Article  CAS  Google Scholar 

  78. Hickman PE, Hourigan LF, Powell LW, Cordingley F, Dimeski G, Ormiston B, et al. Mutations of the HFE gene in patients with hepatocellular carcinoma. Am J Gastroenterol. 2003;98:442–7.

    Article  Google Scholar 

  79. Cauza E, Peck-Radosavljevic M, Ulrich-Pur H, Datz C, Gschwantler M, Schoniger-Hikela M, et al. Mutations of the HFE gene in patients with hepatocellular carcinoma. Am J Gastroenterol.2003;98:442–7.

    Article  CAS  PubMed  Google Scholar 

  80. Tajera K, Shimizu Y, Liver pathology and liver diseases in the elderly. World J Gastroenterol. 2013; 19(4):8459–8467.

    Article  Google Scholar 

  81. Bruguera M. Liver disease in the elderly. Gastroenterologica y Hepatologia 2014;37(9):535–543.

    Article  Google Scholar 

  82. Guttelling JJ, de Man RA, Busschbach JJV, Darlington ASE. Overview of research on health-related quality of life in patients with chronic liver disease. J Med. 2007;65(7):227–231.

    Google Scholar 

  83. Orr JG, Homer T, Tement L, Newton J, McNeil CJ, Hudson M, et al. Heath related quality of life in people with advanced chronic liver disease. J Hepatol. 2014;61(5): 1158–1165.

    Article  PubMed  Google Scholar 

  84. Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001; 96(7):2199–205.

    Article  CAS  PubMed  Google Scholar 

  85. Bownik H, Saab S. Health-related quality of life after liver transplantation for adult recipients. Liver Trans. 2009;15:S42-S49.

    Article  Google Scholar 

  86. Bianich G, Marcesini G, Nicolino F, Grazian R, Sgarbi D, Lognercio C, et al. Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis. 2005; 37(8): 593–600.

    Article  Google Scholar 

  87. Rakoski MO, McCammon RJ, Piette JD, Iwashyna TJ, Marrero JA. Lok AS, et al. Burden of cirrhosis in older Americans and their families: Analysis of the health and retirement study. Hepatology. 2012;55(1):184–191.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Compare Health Funds. Elderly cirrhosis patients strain health system. http://www.medicaldaily.com/elderly-cirrhosis-patients-strain-health-system-239429. Accessed on 19 November 2015.

  89. Kolus K. Study: Elderly with cirrhosis present growing burden on the health care system. Long-Term Living.2002. http://www.Lt/mmagazine.com/news-item/study-elderly-cirrhosis-present-growing-burdenonhealthcaresystem. Accessed on 9 November 2015.

  90. Hsu P, Krajden M, Yoshida EM, Anderson FH, Tomlinson GA, Krahn MD. Does cirrhosis affect quality of life in hepatic cirrhosis impaired patients. Liver Ont 2009. DOI: 10.1111/j.1478-3231.2008.01865.x

  91. Dan AA, Kallman JB, Srivastava R, Younosazai Z, Kino A, Younossi ZM,. Impact of chronic liver disease and cirrhosis on health uptake using SF-6D and health utility index. Liver Transplnt. 2008;14(3):321–6.

    Article  Google Scholar 

  92. Ebeid SM, Ah SH, Kamel HY, Elbaz AA, El-Herire HM. Impact of post hepatitis C, chronic liver disease and hepatocellular carcinoma on health related quality of life. Advances on ageing Res doi. 10.4236/aar.2013.46019.

  93. Gan L, Chittni S, Farrell GC. Mechanisms and implications of age related changes in the liver: Non-alcoholic fatty liver disease in the elderly. Curr Gerontol Geriatr Res. http://dx.doi.org/10.1155/2011/8311536.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nages Nagaratnam .

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Nagaratnam, N., Nagaratnam, K., Cheuk, G. (2017). Chronic Liver Disease. In: Geriatric Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-32700-6_22-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32700-6_22-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32700-6

  • Online ISBN: 978-3-319-32700-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics